FTβ Inhibitors
FTβ inhibitors belong to a distinct chemical class that plays a crucial role in modulating cellular processes by targeting enzymes associated with lipid metabolism. Specifically, FTβ inhibitors are designed to inhibit farnesyltransferase, an enzyme involved in the post-translational modification of proteins. Farnesyltransferase catalyzes the attachment of a farnesyl lipid group to specific proteins, a process known as farnesylation. This modification is essential for the proper functioning of various proteins that regulate cell growth and signal transduction pathways. FTβ inhibitors are characterized by their ability to interfere with this enzymatic activity, thereby disrupting the farnesylation process and altering the function of the modified proteins.
The inhibition of farnesyltransferase by FTβ inhibitors has garnered significant attention in the field of molecular biology and drug discovery due to its potential implications in the modulation of cellular processes associated with cancer and other diseases. By disrupting the farnesylation of specific proteins, these inhibitors may affect the localization, interaction, and overall activity of these proteins within the cell.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tipifarnib | 192185-72-1 | sc-364637 | 10 mg | $720.00 | ||
A non-peptidomimetic quinolone that binds to the CAAX-binding site of FT, preventing its ability to farnesylate target proteins. | ||||||
Lonafarnib | 193275-84-2 | sc-482730 sc-482730A | 5 mg 10 mg | $173.00 $234.00 | ||
A tricyclic compound that inhibits FT by competitively binding to its active site, blocking the binding of farnesyl pyrophosphate. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
A natural product from Streptomyces parvulus that inhibits FT by irreversibly binding to its zinc cofactor. | ||||||
GGTI 298 | 1217457-86-7 | sc-361184 sc-361184A | 1 mg 5 mg | $193.00 $838.00 | 2 | |
Although primarily a geranylgeranyltransferase I inhibitor, it also shows activity against FT at higher concentrations by obstructing the enzyme's substrate binding. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
While primarily a CDK4/6 inhibitor, at higher concentrations it exhibits inhibition of FT by altering the conformation of the enzyme's active site. | ||||||